PTP4A2 and breast carcinoma: The molecular mechanism of the magnesium role in breast cancer etiology can be explained by a recent experimental study which suggested that the over-expression of oncogenic protein tyrosine phosphatase PRL-2 can promote oncogenesis by modulating intracellular magnesium levels through binding with the magnesium transporter [55].